STOCK TITAN

Edgewise Therapeutics officer proposes $39.2K sale

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Edgewise Therapeutics, Inc. (EWTX) officer Joanne Donovan gave notice of a proposed sale of 854 common shares, with an aggregate market value of $39,224.22 and an approximate sale date of November 16, 2026. Morgan Stanley Smith Barney LLC is listed as broker. The notice lists December 26, 2025 as the date of plan adoption or giving of instruction, if relying on Rule 10b5-1.

Proposed sale 854 common shares Approximate sale date: November 16, 2026
Aggregate market value $39,224.22 Value listed for the proposed sale
Shares outstanding 109,482,763 shares Outstanding-share count listed with the proposed sale
Rule 10b5-1 regulatory
"date of plan adoption or giving of instruction, if relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Employee Stock Purchase Plan financial
"Nature of Acquisition Transaction: Employee Stock Purchase Plan"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EWTX shares did Joanne Donovan propose to sell?

Joanne Donovan, an officer of Edgewise Therapeutics (EWTX), gave notice of a proposed sale of 854 common shares, with an aggregate market value of $39,224.22 and an approximate sale date of November 16, 2026.

What Rule 10b5-1 date is listed for Joanne Donovan’s proposed EWTX sale?

The notice lists December 26, 2025 as the date of plan adoption or giving of instruction, if relying on Rule 10b5-1.

How did Joanne Donovan acquire the EWTX shares proposed for sale?

The 854 common shares were acquired from Edgewise through its Employee Stock Purchase Plan on May 15, 2025, with payment recorded as cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading